Cue Health Inc.
HLTHQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | -0.35 | -0.45 |
| FCF Yield | -632.49% | -57.29% | -6.38% | 0.49% |
| EV / EBITDA | 0.03 | -0.80 | 9.59 | -71.01 |
| Quality | ||||
| ROIC | -130.48% | -30.61% | 17.40% | -26.87% |
| Gross Margin | -97.89% | 31.75% | 55.26% | 34.86% |
| Cash Conversion Ratio | 0.37 | 0.58 | -0.11 | -1.95 |
| Growth | ||||
| Revenue 3-Year CAGR | -52.99% | 176.17% | 353.53% | 2,841,828.53% |
| Free Cash Flow Growth | 10.22% | -40.25% | -969.57% | 189.69% |
| Safety | ||||
| Net Debt / EBITDA | 0.11 | 1.26 | -2.18 | 2.73 |
| Interest Coverage | -340.68 | -315.71 | 19.39 | -120.66 |
| Efficiency | ||||
| Inventory Turnover | 9.05 | 4.01 | 3.13 | 0.41 |
| Cash Conversion Cycle | 27.58 | 97.41 | 129.96 | 383.53 |